CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
SMN1 |
Q16637
|
survival of motor neuron 1, telomeric
|
Epigenetic regulator
|
1.6E-02 |
0.454 |
0.769 |
SMN2 |
Q16637
|
survival of motor neuron 2, centromeric
|
|
0.10 |
0.459 |
0.769 |
ATRX |
P46100
|
ATRX chromatin remodeler
|
|
1.00 |
0.452 |
0.808 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
PDGFRA |
P16234
|
platelet derived growth factor receptor alpha
|
Kinase
|
1.00 |
0.415 |
0.808 |
PLK1 |
P53350
|
polo like kinase 1
|
Kinase
|
0.98 |
0.467 |
0.808 |
TAZ |
Q16635
|
tafazzin
|
Enzyme
|
0.73 |
0.477 |
0.808 |
EPHB2 |
P29323
|
EPH receptor B2
|
Kinase
|
1.00 |
0.374 |
0.846 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |
PCNA |
P12004
|
proliferating cell nuclear antigen
|
Nucleic acid binding
|
0.98 |
0.382 |
0.846 |
CXCL12 |
P48061
|
C-X-C motif chemokine ligand 12
|
|
0.12 |
0.379 |
0.846 |
VIM |
P08670
|
vimentin
|
|
0.71 |
0.372 |
0.846 |
MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
PIK3CB |
P42338
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
Kinase
|
1.00 |
0.322 |
0.885 |
PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
PIK3CG |
P48736
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
|
Kinase
|
1.4E-06 |
0.320 |
0.885 |
CRK |
P46108
|
CRK proto-oncogene, adaptor protein
|
|
0.96 |
0.394 |
0.923 |
MAPK14 |
Q16539
|
mitogen-activated protein kinase 14
|
Kinase
|
0.37 |
0.379 |
0.923 |
MMP2 |
P08253
|
matrix metallopeptidase 2
|
Enzyme
|
0.84 |
0.333 |
0.923 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |